Detalles de la búsqueda
1.
How to improve RCHOP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of 21 randomized controlled trials.
Ann Hematol
; 103(5): 1623-1633, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191715
2.
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Am J Hematol
; 98(5): 730-738, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869876
3.
P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.
Europace
; 25(2): 450-459, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413611
4.
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond.
Acta Haematol
; 145(2): 170-175, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879375
5.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583077
6.
Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow.
Br J Haematol
; 204(4): 1129-1130, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185474
7.
Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL).
Med Sci Monit
; 25: 2151-2158, 2019 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30903656
8.
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1671-1682, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29756171
9.
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1747, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943159
10.
Severe Hypocalcemia Due to Skeletal Remineralization After Venetoclax, Bortezomib, and Dexamethasone for Relapsed Multiple Myeloma.
Ann Pharmacother
; 56(9): 1076-1078, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34979809
11.
Blood and platelet transfusion from a donor with presymptomatic Covid-19.
Ann Hematol
; 100(8): 2133-2134, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188469
12.
Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
Br J Haematol
; 190(6): 809, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510577
13.
"Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group.
Ann Hematol
; 93(1): 129-39, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892921
14.
Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils.
J Clin Med
; 13(3)2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38337573
15.
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.
Leuk Lymphoma
; 65(6): 833-842, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497533
16.
Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials.
Thromb Res
; 238: 88-96, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696925
17.
Activated invariant NKT cells regulate osteoclast development and function.
J Immunol
; 186(5): 2910-7, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21278350
18.
Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies.
Thromb Res
; 231: 17-24, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748234
19.
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study.
Cancers (Basel)
; 15(24)2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136391
20.
Statin-induced immunomodulation alters peripheral invariant natural killer T-cell prevalence in hyperlipidemic patients.
Cardiovasc Drugs Ther
; 26(4): 293-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22441892